Japanese drugmaker Shionogi to double COVID-19 vaccine supply to 60 million
The vaccine, which could be the first domestically developed in Japan, can be effective even with half the amount previously deemed necessary, company officials said.
Shionogi aiming to provide Japan's first domestically produced COVID-19 vaccine this year
The drugmaker is currently discussing with the health ministry a framework that would enable the efficacy and safety of the vaccine to be evaluated even with small-scale trials.
New recruits mark first day at work, many joining ceremonies online
Last year many events marking the start of the new business year were canceled due to the spread of the virus that causes COVID-19, but this year some have resumed.
Shionogi unlikely to start shipping COVID-19 vaccines in 2021
The company is making preparations for large-scale, final-phase testing but is facing difficulty securing participants as more and more people are receiving other vaccines.
Why Japan is largely a spectator in the coronavirus vaccine race
A total of 52 vaccine candidates were in clinical evaluation worldwide as of Tuesday, of which only one was Japanese.
Japan-made coronavirus vaccines may not be available until 2022
Only one company in Japan is conducting a trial of a vaccine.
Japan's Shionogi readies COVID-19 vaccine for December trial
The firm plans to put its vaccine candidate into Phase 1 clinical trials in December and shift into Phase 2 by January.
Japanese drug firm Shionogi hit by cyberattack and data breach
Japanese pharmaceutical firm Shionogi & Co. said Thursday that its Taiwanese subsidiary was hit by a cyberattack earlier this month leading to a data breach, although no information regarding the novel coronavirus vaccine it is currently developing was leaked. According to the company, import licenses ...
Japan drugmaker to tie up with universities to develop new test method for coronavirus
Japanese pharmaceutical company Shionogi & Co. said Monday that it will collaborate with universities in the country to put into practical use a new testing method for the novel coronavirus.
Japan pushes homegrown coronavirus vaccines to secure supply
The government is concerned that foreign vaccines may be not widely available in the nation.
Drugmaker Shionogi rushing to launch coronavirus vaccine in 2021
It is rare to study production before getting the results of clinical trials, but the Japanese drugmaker wants a vaccine on the market as fast as possible.
Shionogi to develop coronavirus vaccine, with trials eyed for this year
Shionogi & Co. said Monday it will develop a vaccine for the novel coronavirus with the aim of starting clinical trials this year. The Osaka-based company has decided to develop a recombinant protein vaccine through its subsidiary UMN Pharma Inc. while also seeking to discover ...
